| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
907 |
806 |
$27K |
| 73630 |
|
1,952 |
1,501 |
$26K |
| 17110 |
|
675 |
517 |
$25K |
| 11721 |
|
1,790 |
1,436 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
629 |
560 |
$12K |
| L3020 |
Foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each |
50 |
50 |
$8K |
| 11055 |
|
683 |
588 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
266 |
221 |
$7K |
| A5500 |
For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe |
80 |
51 |
$3K |
| 11720 |
|
427 |
370 |
$3K |
| 11056 |
|
290 |
198 |
$3K |
| 20550 |
|
27 |
24 |
$876.41 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
29 |
13 |
$630.98 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
443 |
413 |
$454.41 |
| 73610 |
|
21 |
13 |
$273.73 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
463 |
410 |
$152.95 |